Skip to content

Codeine Ultrarapid Metabolism Of C1837160

Published: July 22, 2026Updated: August 20, 2026

A genetic variation affecting how quickly the body processes codeine. Individuals with this variation may experience stronger effects from standard codeine doses.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Mild respiratory depression

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Increased drowsiness

(nervous system)

Nausea

(gastrointestinal)

Constipation

(gastrointestinal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Codeine avoidance

Complete avoidance of codeine-containing medications as the primary management strategy. Patients should inform all healthcare providers and pharmacists about this genetic predisposition.

lifestyle
2

Exercise prescription and weight management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Alternative pain management

Using alternative analgesics such as acetaminophen, ibuprofen, or other non-opioid pain relievers. For conditions requiring opioids, using medications that are not affected by CYP2D6 metabolism.

medication

Additional treatment options

Pharmacogenomic-guided prescribing

Healthcare providers should review pharmacogenomic information before prescribing medications metabolized by CYP2D6. Many drugs besides codeine may be affected by this enzyme polymorphism.

medication

Non-pharmacological pain management

Incorporating physical therapy, acupuncture, cognitive behavioral therapy, or other non-pharmacological approaches to reduce reliance on opioid medications for pain control.

complementary

Patient and family education

Comprehensive education about the genetic basis of ultrarapid metabolism, associated risks with codeine, and importance of communicating this information to healthcare providers and family members.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Codeine Ultrarapid Metabolism Of C1837160?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Crews KR, Gaedigk A, Leeder JS, McLeod HL. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and codeine therapy. Clin Pharmacol Ther. 2014.

guideline2014View source →
2

St Sauver JL, Bielinski SJ, Olson JE, Bell EM, Caravello T, Weinshilboum RM. Pharmacogenomic factors influencing opioid efficacy and adverse events. Pharmacogenomics. 2015.

review2015View source →
3

Feng J, Wang J, Zhang Z, Chen J. Clinical implications of CYP2D6 polymorphisms for codeine metabolism. Pharmacogenomics J. 2018.

review2018View source →
4

Dean L. Codeine Therapy and CYP2D6 Genotype. Med Genet Summ. 2012.

Medication Comparisons

Compare medications used to treat Codeine Ultrarapid Metabolism Of C1837160. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy